[go: up one dir, main page]

UA48986C2 - Drug for treating cardiovascular diseases "cardiophyt" - Google Patents

Drug for treating cardiovascular diseases "cardiophyt"

Info

Publication number
UA48986C2
UA48986C2 UA98041949A UA98041949A UA48986C2 UA 48986 C2 UA48986 C2 UA 48986C2 UA 98041949 A UA98041949 A UA 98041949A UA 98041949 A UA98041949 A UA 98041949A UA 48986 C2 UA48986 C2 UA 48986C2
Authority
UA
Ukraine
Prior art keywords
drug
herb
cardiophyt
leaves
cardiovascular diseases
Prior art date
Application number
UA98041949A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олексій Генадійович Чистяков
Original Assignee
Олексій Генадійович Чистяков
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олексій Генадійович Чистяков filed Critical Олексій Генадійович Чистяков
Priority to UA98041949A priority Critical patent/UA48986C2/en
Priority to RU98115635A priority patent/RU2137496C1/en
Publication of UA48986C2 publication Critical patent/UA48986C2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The drug for treating the cardiovascular diseases "Cardiophyt" is developed. The drug possesses the cardiotonic, coronarolytic, hypotensive, antihypoxic, antothrombotic and sedative activity and is devoid of the side effects. The drug represents the tincture prepared from 14 medicinal herbs with the following ratio of the components in mass %: hawthorn flowers0.6-0.8elder flowers0.6-0.8peppermint leaves 0.6-0.8nettle leaves 0.3-0.5mistletoe leaves (fresh) 0.5-0.6lychnis herb 0.6-0.8sweet clover herb 0.6-0.8lily-of-the-valley herb 0.6-0.8motherwort herb0.6-0.8thyme herb 0.6-0.8amorpha fruits0.6-0.8rhizome and root of valerian 0.9-1.1rhizome and root of licorice0.6-0.8seeds of horse-chestnut tree 0.9-1.2ethanol 40% the rest 1 f.f., 4 tables.
UA98041949A 1998-04-16 1998-04-16 Drug for treating cardiovascular diseases "cardiophyt" UA48986C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UA98041949A UA48986C2 (en) 1998-04-16 1998-04-16 Drug for treating cardiovascular diseases "cardiophyt"
RU98115635A RU2137496C1 (en) 1998-04-16 1998-08-13 Preparation "kardiofit" for treatment of patients with cardiovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA98041949A UA48986C2 (en) 1998-04-16 1998-04-16 Drug for treating cardiovascular diseases "cardiophyt"

Publications (1)

Publication Number Publication Date
UA48986C2 true UA48986C2 (en) 2002-09-16

Family

ID=21689259

Family Applications (1)

Application Number Title Priority Date Filing Date
UA98041949A UA48986C2 (en) 1998-04-16 1998-04-16 Drug for treating cardiovascular diseases "cardiophyt"

Country Status (2)

Country Link
RU (1) RU2137496C1 (en)
UA (1) UA48986C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012286B1 (en) * 2007-10-26 2009-08-28 Валерий Константинович Печаев Medical preparation for treating sedative and cardiologic disorders
RU2704323C1 (en) * 2019-04-08 2019-10-28 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Preparation for recovery of cardiovascular system, having cardioprotective, sedative and hypotensive action
RU2767675C1 (en) * 2021-02-02 2022-03-18 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method for producing and pharmacological activity of an antioxidant agent increasing physical performance

Also Published As

Publication number Publication date
RU2137496C1 (en) 1999-09-20

Similar Documents

Publication Publication Date Title
Heesacker et al. In a different voice, revisited: Men, women, and emotion.
DK0731699T3 (en) Method of reducing body fat in animals by administration of conjugated linoleic acid
DE69931907D1 (en) HAGA BUTTER COMPOSITIONS AS AN ANTI-INFLAMMABLE NATURAL MEDICAMENT TO FACILITATE / REDUCE SYMPTOMS RELATING TO INFLAMMATION AND ARTHRITIS
Ziyyat et al. Cardiovascular effects of Arbutus unedo L. in spontaneously hypertensive rats
EE04038B1 (en) Formoterol inhalation dosage form, bulk density 0.28 to 0.38 g / ml, method of preparation and use
UA48986C2 (en) Drug for treating cardiovascular diseases "cardiophyt"
NO894222L (en) PROCEDURES FOR THE TREATMENT AND PROPHYLAXY OF PNEUMOCYTIS CARINII PNEUMONI AND OTHER DISEASES AND COMPOUNDS AND FORMULATIONS FOR USE IN THE ABOVE METHODS.
Caplan Population-oriented psychiatry.
DE3787477D1 (en) Drug that can be administered nasally, process for its preparation and its use.
ATE275409T1 (en) COMPOSITION CONTAINING COMPOUNDS WITH ADRENERGIC ACTIVITY AND HERBAL EXTRACTS OF CRATAEGUS AND GINGKO FOR THE TREATMENT OF OVERWEIGHT AND OBESITY
JPS6483020A (en) Medicinal composition for preventing or treating aids
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
Dominguez et al. Comparison of triazolam and placebo in the treatment of insomnia in depressed patients.
Von Ardenne et al. Measurements of the increase in the difference between the arterial and venous Hb-O2 saturation obtained with daily administration of 200 mg standardized ginseng extract G115 for four weeks. Long-term increase of the O2 transport into the organs and tissues of the organism through biologically active substances
JPH11180889A (en) Agent for treating dermatitis containing extracted ingredient from ganoderma lucidum karst.
NO20011371L (en) Chemokine receptor antagonist and cyclosporin in combined therapy
RU94003867A (en) Anticancerogenic treatment-and-prophylactic additive for pouring syrup dragee
ATE66375T1 (en) USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES.
MD916G2 (en) Ungent for stomatologic deseases treatment
RU95119282A (en) COMPOSITION OF INGREDIENTS FOR MEDICINAL PRODUCT
Covelli et al. Interleukin-1 beta plasma secretion during diurnal spontaneous and induced sleeping in healthy volunteers
Murray Review of international safety data for lisinopril-hydrochlorothiazide combination treatment
Applestone LIFEbeat, the music industry fights AIDS
Bardin et al. Norplant contraceptive implants: a new contraceptive for women
Adolfsson Time dependence of dipyridamole-induced increase in skeletal muscle capillarization